QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Pfizer (PFE) SEC Filings & 10K Form

$25.89
-0.70 (-2.63%)
(As of 03/4/2024 ET)

Recent Pfizer SEC Filings

DateFilerForm TypeView
03/01/2024
12:28 PM
BOSHOFF CHRISTOFFEL (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:53 AM
Dolsten Mikael (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:44 PM
BOSHOFF CHRISTOFFEL (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
Dolsten Mikael (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
LANKLER DOUGLAS M (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
Pfizer (Issuer)
SAHNI PAYAL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:46 PM
Pfizer (Issuer)
SUSMAN SALLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:47 PM
McDermott Michael (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
12:17 PM
Pfizer (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
11:52 AM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
11:53 AM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
11:55 AM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:48 PM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G/A
02/14/2024
2:31 PM
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G/A
02/14/2024
1:19 PM
Akero Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G/A
02/14/2024
1:24 PM
Cellectis S.A. (Subject)
Pfizer (Filed by)
Form SC 13G/A
02/14/2024
1:29 PM
AN2 Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G/A
01/30/2024
7:04 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
12:04 PM
Pfizer (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
3:20 PM
Haleon plc (Subject)
Pfizer (Filed by)
Form SC 13D/A
01/10/2024
3:38 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
3:12 PM
Longboard Pharmaceuticals, Inc. (Subject)
Pfizer (Filed by)
Form SC 13D/A
01/02/2024
4:42 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:42 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:42 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:49 PM
Echevarria Joseph (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:49 PM
NARAYEN SHANTANU (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:49 PM
Pfizer (Issuer)
Quincey James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:49 PM
Pfizer (Issuer)
SMITH JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
5:05 PM
BOSHOFF CHRISTOFFEL (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
3:20 PM
de Germay Alexandre (Reporting)
Pfizer (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2023
3:37 PM
Dolsten Mikael (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
11:34 AM
LANKLER DOUGLAS M (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
11:35 AM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
8:30 AM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
8:30 AM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
8:31 AM
Gottlieb Scott (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
6:51 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
6:51 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
6:44 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:35 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
8:23 AM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
8:23 AM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
8:23 AM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:22 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:22 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:23 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
5:18 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
5:19 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
5:19 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
7:04 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2023
4:29 PM
Allogene Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13D/A
10/18/2023
3:27 PM
Cerevel Therapeutics Holdings, Inc. (Subject)
Pfizer (Filed by)
Form SC 13D/A
10/16/2023
3:08 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:08 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:08 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
4:30 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
2:32 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
2:32 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
2:32 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
6:25 PM
Echevarria Joseph (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
6:25 PM
NARAYEN SHANTANU (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
6:25 PM
Pfizer (Issuer)
Quincey James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
6:25 PM
Pfizer (Issuer)
SMITH JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
5:11 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
5:11 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
5:11 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
1:30 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
1:30 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
1:30 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
2:48 PM
Pao William (Reporting)
Pfizer (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:08 PM
Haleon plc (Subject)
Pfizer (Filed by)
Form SC 13D/A
09/01/2023
12:36 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
12:36 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
12:36 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
12:21 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
12:21 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
12:21 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
4:13 PM
BOSHOFF CHRISTOFFEL (Reporting)
Pfizer (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2023
6:23 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
6:13 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
6:22 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
7:09 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
2:03 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
2:03 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
2:03 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
8:10 AM
Caribou Biosciences, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G
07/05/2023
9:14 AM
Echevarria Joseph (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
9:14 AM
NARAYEN SHANTANU (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
9:14 AM
Pfizer (Issuer)
Quincey James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
9:14 AM
Pfizer (Issuer)
SMITH JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:16 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:16 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:16 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
1:51 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/20/2023
1:45 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/18/2023
3:37 PM
Pfizer (Filer)
Pfizer Investment Enterprises PTE Ltd (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:PFE) was last updated on 3/4/2024 by MarketBeat.com Staff